Our Pricing

Understanding Lumps After Weight Loss Injections

A lump after injection is one of the most common injection site reactions reported by patients using GLP-1 weight loss medications like Ozempic, Wegovy, and Mounjaro. While often harmless, understanding what causes these lumps and how to manage them properly can help you continue your weight loss journey safely and comfortably.

What Causes a Lump After Injection?

When you inject subcutaneous medications like semaglutide or tirzepatide, you're depositing liquid medication into the fatty tissue layer beneath your skin [1]. A lump after injection typically occurs for one of three reasons: lipohypertrophy (fatty tissue build-up from repeated injections in the same site), localised inflammation as your body responds to the medication, or improper injection technique causing medication to pool rather than disperse evenly.

Lipohypertrophy develops when you inject repeatedly into the same 2-3cm area over weeks or months [2]. The fatty tissue thickens and hardens in response to repeated trauma, creating firm lumps that can persist for months. This is particularly common with daily injections like Saxenda, though it can occur with weekly injections if you don't rotate sites properly.

Most injection site lumps are benign and resolve within 3-7 days without intervention. However, a lump after injection that persists beyond two weeks, becomes increasingly painful, shows signs of infection (redness, warmth, pus), or is accompanied by systemic symptoms warrants immediate contact with your prescriber.

How to Treat a Lump After Injection at Home

For uncomplicated injection site lumps, simple home measures can accelerate resolution and reduce discomfort. Apply a cool compress for 10-15 minutes immediately after injection to reduce inflammation and slow medication absorption, which helps prevent pooling [3]. After the first 24 hours, switch to warm compresses to improve blood flow and encourage dispersion of the medication.

Gentle massage of the injection site in circular motions for 30-60 seconds after injecting can help distribute the medication through the subcutaneous tissue, though this should only be done if your prescriber hasn't advised otherwise. Avoid pressing directly on a formed lump, as this can increase discomfort without providing benefit.

Over-the-counter pain relief such as paracetamol may help manage any associated discomfort, though most lumps are painless or only mildly tender. Avoid aspirin or ibuprofen in the first 24 hours after injection, as these can theoretically increase bruising risk at the injection site.

When Home Treatment Isn't Enough

Contact your prescriber immediately if your lump after injection is accompanied by fever, spreading redness beyond 5cm diameter, severe pain that worsens rather than improves, or any discharge from the injection site. These may indicate infection or abscess formation requiring antibiotic therapy [4].

Proper Injection Technique to Prevent Lumps

The single most effective way to prevent a lump after injection is systematic site rotation. For weekly injections like Mounjaro or Wegovy, divide your abdomen into four quadrants and rotate clockwise each week, ensuring you never inject within 5cm of your previous injection site [1]. For daily injections like Saxenda, you'll need a more detailed rotation pattern across abdomen, thighs, and upper arms.

Injection angle and depth significantly affect lump formation. Pinch a fold of skin firmly between thumb and forefinger, insert the needle at 90 degrees to the skin surface, and inject slowly over 5-10 seconds. Rapid injection forces medication into tissue faster than it can disperse, creating a depot that manifests as a visible lump.

Allow your medication pen to reach room temperature before injecting — cold medication is more viscous and disperses less readily through fatty tissue. Remove your pen from the refrigerator 30 minutes before your scheduled injection time, but never use external heat sources to warm it.

Choosing the Right Injection Site

The abdomen generally produces fewer lumps than thighs or upper arms because abdominal subcutaneous tissue is typically thicker and better vascularised [2]. However, avoid injecting within 5cm of your navel, any scars, or areas with existing lipohypertrophy, as medication absorption is unpredictable in these locations.

Lump After Injection: Comparing GLP-1 Medications

Different GLP-1 receptor agonists have varying injection volumes and formulations that affect lump formation rates. Mounjaro delivers between 0.25ml and 0.5ml per injection depending on dose, whilst Wegovy delivers 0.5ml to 0.75ml at higher dose tiers [1]. Larger injection volumes theoretically increase lump risk, though proper technique matters more than volume in clinical practice.

Saxenda requires daily injections of up to 3mg in 0.6ml volume, which creates the highest cumulative injection frequency of any licensed GLP-1 treatment. This daily administration increases lipohypertrophy risk compared to weekly injections, making meticulous site rotation absolutely essential for Saxenda users.

At Cured Pharmacy, our clinical team provides detailed injection technique guidance during your free online consultation, tailored to whichever medication your UK prescriber determines is most appropriate for your circumstances. All GLP-1 treatments are subject to clinical assessment and require a valid prescription from a UK-registered prescriber.

Lipohypertrophy vs Normal Injection Site Reactions

Understanding the difference between temporary injection site reactions and developing lipohypertrophy helps you know when to adjust your injection routine. A normal lump after injection is soft, slightly tender, and resolves within 3-7 days as the medication disperses and any minor inflammation settles [3].

Lipohypertrophy presents as firm, rubbery lumps that persist for weeks or months and don't resolve between injections. These areas may feel numb or have reduced sensation, and medication injected into lipohypertrophic tissue is absorbed erratically — sometimes too slowly, sometimes in unpredictable bursts — which can affect your treatment efficacy and increase side effect risk [4].

If you've developed lipohypertrophy, completely avoid those areas for at least 3-6 months to allow the tissue to recover. Map your injection sites using a body diagram or smartphone app to ensure you're genuinely rotating rather than unconsciously favouring certain areas. Your prescriber can provide injection site mapping tools during your consultation.

Monitoring Your Injection Sites

Perform a weekly visual and tactile inspection of all potential injection sites. Run your fingertips across your abdomen, thighs, and upper arms feeling for any firm areas, lumps, or texture changes. Early detection of lipohypertrophy allows you to avoid those sites before the condition worsens.

When to Contact Your Prescriber About Injection Lumps

Most injection site lumps require no medical intervention, but certain presentations warrant professional assessment. Contact your prescriber if a lump after injection persists beyond two weeks, continues to grow rather than shrink, or is accompanied by systemic symptoms like fever, chills, or malaise [4].

Signs of potential infection include spreading redness (erythema extending beyond the immediate injection site), increasing warmth to touch, throbbing pain that worsens over 24-48 hours, or any purulent discharge. Infected injection sites require prompt antibiotic therapy and temporary cessation of injections in that area.

If you're developing multiple persistent lumps across different injection sites despite proper rotation technique, this may indicate an unusual sensitivity to the medication formulation or excipients. Your prescriber may need to assess whether continuing the current medication is appropriate or whether switching to an alternative treatment would be beneficial. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team are available to discuss any injection-related concerns during your consultation.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frid, A. H., et al. (2016). New Injection Recommendations for Patients with Diabetes. Diabetes & Metabolism, 42(4), S3–S23. https://doi.org/10.1016/S1262-3636(16)30006-8
3. Gibney, M. A., et al. (2010). Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Current Medical Research and Opinion, 26(6), 1519–1530. https://doi.org/10.1185/03007995.2010.481203
4. Blanco, M., et al. (2013). Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes & Metabolism, 39(5), 445–453. https://doi.org/10.1016/j.diabet.2013.05.006

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. If you experience signs of infection at an injection site (spreading redness, warmth, pus, fever), seek immediate medical attention.